PENG vs. Femoral Nerve Block for Pain Control in Hip Surgery
Comparative Study Between Continous Ultrasound Guided Pericapsular Nerve Group (PENG) Block Versus Femoral Nerve Block For Perioperative Pain Control In Hip Surgeries
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The aim of this study is to compare the efficacy of the ultrasound- guided pericapsular nerve group (PENG) block versus the femoral nerve block (FNB) for postoperative pain control in patients undergoing hip surgeries, specifically evaluating pain scores and quadriceps strength.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 15, 2027
May 19, 2026
May 1, 2026
1 year
January 24, 2026
May 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale (VAS) Score for Pain at 24 Hours.
A scale from 0 to 10 (0 = no pain, 10 = worst imaginable pain). Patients will be asked to rate their pain level at rest.
24 hours postoperatively.
Secondary Outcomes (2)
Quadriceps Muscle Strength
6, 12, and 24 hours post-op.
Total Opioid Consumptiont
First 3 days
Study Arms (2)
PENG block group
EXPERIMENTALParticipants in this group will receive a preoperative, ultrasound-guided Pericapsular Nerve Group (PENG) block. Under sterile conditions and ultrasound guidance (curvilinear or linear probe), the needle will be inserted in-plane to target the facial plane between the psoas tendon and the pubic ramus. A volume of 20-25 mL of 0.25% Bupivacaine will be injected following negative aspiration
Femoral nerve block group
ACTIVE COMPARATORParticipants in this group will receive a preoperative, ultrasound-guided Femoral Nerve Block (FNB). Using a linear probe, the femoral nerve will be identified lateral to the femoral artery and deep to the fascia iliaca. A volume of 20-25 mL of 0.25% Bupivacaine will be injected to achieve circumferential spread around the nerve trunk
Interventions
Regional anesthesia technique involving the injection of local anesthetic into the myofascial plane between the psoas muscle and the iliopubic eminence.
Regional anesthesia technique involving the injection of local anesthetic deep to facia iliaca and lateral to femoral artery circulating femoral nerve trunk.
Eligibility Criteria
You may qualify if:
- Aged 40 years or older.
- Presenting for hip surgeries
- No contraindications to regional anesthesia.
- Time of surgery up to 3 hours
- ASA I-III
- Able to provide written informed consent.
- Able to reliably report pain and other symptoms to the research team.
- Undergoing elective or emergency hip surgeries.
You may not qualify if:
- Inability to provide first-person consent due to cognitive impairment.
- Presence of a language barrier that would preclude reliable reporting of symptoms or understanding study procedures.
- More than ASA III. 4
- Previous neurological deficit in the lower limbs.
- Local infection at block area.
- Lengthy surgeries more than 3 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Taghreed Saker, MD
Benha University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant lecetruer
Study Record Dates
First Submitted
January 24, 2026
First Posted
May 19, 2026
Study Start
May 15, 2026
Primary Completion (Estimated)
May 15, 2027
Study Completion (Estimated)
May 15, 2027
Last Updated
May 19, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share